Results and Discussion

Nf2 Is Expressed in the Preimplantation Embryo
Although multiple inputs have been proposed to regulate core Hippo signaling, the membrane-associated FERM domain protein neurofibromatosis 2 (Nf2, the ortholog of Drosophila Merlin) remains the only upstream component shown to be required for Hippo signaling across a broad range of cell types [2] [3] [4] [5] [6] and to be genetically required for Hippo signaling in vivo [6, 7] . Given its requirement for Hippo signaling in other cell types, we reasoned that Nf2 might also play a role upstream of the Hippo pathway kinases Lats 1 and 2 (Lats1/2) and Yap in the segregation of trophectoderm (TE) and inner cell mass (ICM). To determine whether this could be the case, we first investigated its expression profile during preimplantation development. We performed qPCR on pools of embryos at nine different preimplantation stages and found that, while it could be detected throughout preimplantation development, Nf2 mRNA was especially abundant prior to the two-cell stage, suggesting that it is maternally deposited ( Figure 1A ). To examine the localization of Nf2 protein in the preimplantation embryo, we cultured embryos that had been injected with GFP-tagged Nf2 mRNA to the morula or early blastocyst stage and stained them for GFP. Nf2-GFP appeared highly enriched throughout the plasma membrane in both inside and outside cells ( Figure 1C ). Thus, while Nf2 is maternally deposited and present throughout preimplantation development, its localization does not appear to be differentially regulated between inside and outside cells of the early embryo.
DnNf2 Causes Yap Mislocalization and Cdx2 Misexpression in Inside Cells
We initially assessed Nf2 function by injecting two-cell embryos with mRNA encoding a dominant-negative form of the protein (dnNf2) (see Figure S1A available online) [8, 9] , which should inhibit the activity of all Nf2 in the preimplantation embryo, regardless of its maternal or zygotic origin. As a positive control, we used mRNA encoding a kinase-dead, dominant-negative form of Lats2 (kdLats2) [1] . After injection, embryos were allowed to develop to the morula stage and stained to examine Yap localization. Consistent with what has been shown previously [1] , the presence of kdLats2 caused Yap to localize to the nuclei of inner cells at the morula stage, where it is normally cytoplasmic ( Figure S2B) . A similar mislocalization of Yap was observed in inside cells of dnNf2-injected embryos. In contrast, a mixture of mRNAs coding for the kinase-dead forms of the Hippo kinases Mst1 and 2 (kdMst1/2) [10] , thought to phosphorylate and activate Lats1/2 [11] , had no effect on Yap localization. This observation is consistent with other recent data suggesting that although they have been considered central to the core Hippo kinase cascade, Mst1/2 may not be required for Hippo pathway activation in all cell types [5, 12] . In the context of the early embryo, another kinase may be required for Lats1/2 activation, or Lats1/2 activation may occur in a phosphorylation-independent manner.
In addition to inhibiting Nf2 and Lats1/2 function, we also investigated the consequences of overexpressing these proteins in the preimplantation embryo. In agreement with previous work [1] , we found that injection of wild-type Lats2 mRNA was sufficient to sequester Yap into the cytoplasm of outside cells ( Figure S2C ). In contrast, however, introduction of even very high concentrations of wild-type Nf2 mRNA had no discernible effect on Yap localization in outside cells. These results suggest that, although it is required for Yap phosphorylation in inside cells of the embryo, excess Nf2 alone is not sufficient to induce Yap phosphorylation in outside cells.
To examine the effects of dnNf2 in more detail, we generated mosaic embryos by coinjecting this mRNA, along with GFP mRNA to act as a lineage tracer, into only one cell at the two-cell stage (Figure 2A ). Consistent with our results in the morula, we found that Yap localized to the nuclei of inside cells expressing dnNf2 at the early blastocyst stage ( Figures 2B and  2C ). This effect was cell autonomous, as Yap remained cytoplasmic in inside cells not expressing dnNf2. Notably, despite causing Yap mislocalization throughout preimplantation development, dnNf2 expression did not significantly affect the ability of cells to contribute to inside versus outside cell populations at the morula, early blastocyst, or late blastocyst *Correspondence: janet.rossant@sickkids.ca stages ( Figure S1E ), indicating that Nf2 activity and Yap phosphorylation are likely downstream of the mechanisms controlling positional allocation in the embryo. DnNf2 also caused ectopic Cdx2 expression in the inside cells of early blastocysts ( Figures 2D and 2E ), indicating that the nuclear-localized Yap in these cells is transcriptionally active.
Levels of phosphorylated Yap in injected blastocysts were visibly lower in dnNf2-expressing inside cells ( Figure S1D ), suggesting that dnNf2 exerts its influence by blocking Lats kinase phosphorylation of Yap rather than by some parallel mechanism. To test this, we asked whether expression of excess Lats kinase could rescue the effects of dnNf2. We first injected both cells of the embryo at the two-cell stage with dnNf2 mRNA and then immediately reinjected one of these two cells with a high level of Lats2 mRNA along with GFP (Figure 2F) . Strikingly, this overexpression of Lats2 was able to rescue the Yap localization defects caused by dnNf2 ( Figures  2G and 2H ), suggesting that, in agreement with current models of Hippo signaling [1] , Nf2 acts through the Lats kinases to influence Yap phosphorylation in the preimplantation embryo.
To better understand the relationship between the Lats kinases and Nf2 in this context, we examined Lats1/2 localization by injecting embryos with GFP-tagged Lats2 mRNA or by staining for Lats1. We found that Lats1/2 were apically enriched at the compacted eight-cell stage and remained apical in outside cells as development proceeded ( Figure S1F ). In contrast, in inside cells Lats1/2 were distributed evenly throughout the cytoplasm (and weakly at the plasma membrane in the case of Lats1). These differences in Lats1/2 localization between inside and outside cells are in contrast to the uniform membrane localization of Nf2-GFP ( Figure 1C ).
Maternal Nf2 Partially Rescues Hippo Signaling in Zygotic Mutants
Because of its transient nature, injection of dnNf2 mRNA cannot be used to determine the importance of Nf2 and Hippo signaling in later blastocyst development and postimplantation survival. To more fully assess the role of Nf2 in mouse development, we therefore reexamined the effects of genetic deletion of Nf2 using a previously generated floxed allele [13] . Although it has previously been reported that zygotic Nf2 mutants survive until early postimplantation stages [14] , the earlier development of these embryos has not been investigated in detail. Thus, we first examined Yap localization in Nf2 zygotic mutants generated by intercrossing mice heterozygous for a fully Cre-deleted form of the floxed Nf2 allele ( Figure S2A ). We found that Yap localization in zygotic mutant blastocysts was mildly affected: a subset of inside cells showed strongly nuclear Yap, but the majority of inside cells lacked this clear nuclear accumulation ( Figures 3A and 3B ). Similarly, a subset of inside cells in the mutant blastocysts expressed Cdx2, but most inside cells remained Cdx2 negative ( Figures 3A and 3C ). Notably, nuclear Yap often colocalized with Cdx2 expression in mutant inside cells ( Figure 3A ). Given that these embryos implant and survive until later stages [14] , it is likely that this small population of potentially misspecified cells is excluded from the ICM as the embryo develops.
One explanation for the comparatively mild Yap localization defects observed in zygotic mutant blastocysts, especially given our dominant-negative results, could be an incomplete elimination of Nf2 protein in these embryos. Given the expression of Nf2 mRNA in the oocyte and early embryo ( Figure 1A ), maternally inherited Nf2 could be sufficient to partially rescue Hippo signaling in zygotic mutants. To test this, we made use of a female germline-specific Zp3-Cre [15] that eliminated wild-type Nf2 mRNA from oocytes carrying the floxed allele ( Figure 1B ). Nf2 flox/flox ; Zp3-Cre Cre/+ females were crossed with Nf2 del/+ males to generate embryos deficient in both maternal and zygotic Nf2 as well as littermates deficient in maternal Nf2 but zygotically heterozygous (Figure S2B ). When these embryos were allowed to develop to the blastocyst stage, Yap was strongly nuclear and Cdx2 was ectopically expressed in virtually every inside cell of maternal-zygotic mutant early blastocysts ( Figures 3D-3F) . Notably, Yap and Cdx2 were unaffected in zygotically heterozygous littermates ( Figures 2D-2F ), indicating that maternal Nf2 is only important when zygotic transcription has been affected.
Inside Cells of Maternal-Zygotic Mutant Blastocysts
Resemble the TE and Fail to Form ICM Although the mislocalized nuclear Yap in inside cells of maternal-zygotic Nf2 mutants clearly leads to ectopic Cdx2 expression, whether this represents a true switch in cell fate from ICM to TE remains to be determined. We allowed maternal-zygotic mutant blastocysts to develop in vitro for another 24 hr, until the late blastocyst stage, and examined them for expression of other factors involved in TE specification. Because of their normal Yap localization and Cdx2 expression at both the early and late blastocyst stage ( Figures  3D, S3A , and S3B), zygotically heterozygous littermates were used as controls in these experiments. Although often smaller in volume than littermates, maternal-zygotic mutant late blastocysts contained the same number of inside and outside cells ( Figure S3C ). However, unlike littermates, the inside cells of maternal-zygotic mutants at this stage ectopically expressed the TE-specific transcription factors Eomes, Tcfap2c, and Gata3 [16] (Figures 4A-4C ). Beyond ectopic expression of lineage markers, we also observed cellular and morphological changes to maternalzygotic inside cells that suggested they had adopted a TElike phenotype. In littermates at the late blastocyst stage, outer TE cells formed a normal-looking polarized epithelium with an outward-facing apical domain labeled by aPKCz and an inward-facing basolateral domain labeled by the Na/K-ATPase b1 subunit (Atp1b1; Figures 3D and 3E) . In apolar inside cells, aPCKz was cytoplasmically localized and Atp1b1 was entirely absent. In outside cells of maternal-zygotic mutant late blastocysts the distribution of these two markers was relatively undisturbed, but in inside cells aPCKz was often aberrantly localized throughout the plasma membrane with occasional regions of asymmetric accumulation, while Atp1b1 was ectopically expressed (Figures 3D and 3E) . Additionally, the tight junction (TJ) marker ZO-1, normally seen in discrete TJ-associated punctae only in outer cells, could sometimes be observed forming small punctae or larger aggregations at the plasma membranes of mutant inside cells ( Figure 3F ). Such changes suggest that the inside cells of maternalzygotic mutant late blastocysts have begun to take on an epithelial character, though they lack the positional cues to establish proper apicobasal polarity. Consistent with the expanded expression domain of Atp1b1, a factor involved in fluid accumulation during blastocoel formation [17] , many maternal-zygotic mutant embryos formed additional small We next assessed whether, in addition to adopting TE-like characteristics, these mutant inside cells had entirely lost their normal ICM identity. We tested maternal-zygotic mutant and control littermate late blastocysts with antibodies to Oct4, which marks the entire ICM [18, 19] , as well as Nanog, which marks the epiblast, and Gata6, which marks the primitive endoderm [20] . All three markers were normally distributed in littermate controls but were entirely absent from all cells in maternal-zygotic mutant embryos (Figures 4G and 4H) . We also allowed maternal-zygotic and littermate blastocysts to develop for another 6 days in standard embryonic stem cell (ESC) conditions and found that, while littermates formed normal-looking ESC outgrowths atop a layer of trophoblast giant cells, maternal-zygotic mutants generated only a trophoblast layer ( Figure 4I ). When blastocysts were outgrown in 2i conditions [21] followed by passaging to derive stable ESC lines, only lines corresponding to the zygotically heterozygous littermate genotype could be obtained ( Figure 4J ). Finally, to confirm that the lack of ICM or its derivative lineages in maternal-zygotic mutants is lethal in vivo, we performed crosses between Nf2 flox/flox ;Zp3-Cre Cre/+ females and Nf2 del/+ males and genotyped resulting embryos at E6.5. While morphologically normal littermates were obtained at the expected frequency, no intact maternal-zygotic mutants could be recovered apart from two small, partially resorbed cell masses ( Figure 4K ). These embryos are thus highly reminiscent of other mutants that fail to specify a pluripotent ICM [18, 22, 23] , indicating that formation of excess TE in maternal-zygotic Nf2 mutants occurs at the expense of normal ICM development. Here, we have identified a role for Nf2 upstream of Hippo signaling in segregating the ICM from the TE during mouse preimplantation development. We show that Nf2 is required for Lats1/2-dependent Yap phosphorylation in inside cells of the embryo. Furthermore, a combination of maternal and zygotic Nf2 is present during preimplantation development, and both of these pools must be removed to entirely misregulate Yap localization. In these maternal-zygotic mutants, inside cells adopt a broadly TE-like developmental program and fail to generate the ICM or its derivative lineages, resulting in periimplantation lethality. This demonstrates for the first time that the activation of Hippo signaling in inside cells of the preimplantation embryo is absolutely required for the formation of a fully functional ICM and that, in its absence, all cells will revert to a TE fate, regardless of their position in the embryo.
The exact molecular mechanism by which Nf2 participates in Hippo signaling in inside cells of the embryo remains to be elucidated, but several lines of evidence suggest that adherens junctions (AJs) may be involved. Embryos deficient in both maternal and zygotic E-cadherin have mislocalized Yap and ectopic Cdx2 expression in their inside cells, indicating a defect in Hippo signaling [24] , and the AJ component a-catenin, which participates in Hippo signaling in the mammalian epidermis [5, 25] , can interact directly with Nf2 [26] . Additionally, other work by Hirate et al. published in this issue of Current Biology demonstrates that Nf2 can facilitate an interaction between the AJ component E-cadherin and angiomotin (Amot), another component required for Hippo signaling in inside cells of the preimplantation embryo [27] . Together, these data suggest that a complex containing AJ components, Nf2, and Amot forms in inside cells to facilitate the phosphorylation of Yap.
Our observation that Nf2 overexpression alone is insufficient to alter Yap localization in outside cells suggests that some other component or components required for active Hippo signaling may be absent or actively blocked in these cells. The apical localization of Lats1/2 may represent one such mechanism preventing active Hippo signaling in outside cells. Interestingly, Amot also localizes to the apical domain of polarized embryos [27] . Such localization may serve to physically sequester Lats1/2 and Amot away from an AJ-Hippo signaling complex or may bring them into proximity with some additional pathway inhibitor or inhibitors. Further work will be required to identify the factors responsible for this localization and to understand its specific consequences for Hippo signaling in outside cells of the preimplantation embryo.
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(I) Representative images of m2z2Nf2 and m2z+Nf2 outgrowths after 6 days of culture in standard ESC conditions. (J) Numbers and genotypes of ESC lines derived from m2z2Nf2 and m2z+Nf2 blastocysts. (K) Numbers of m2z2Nf2 and m2z+Nf2 embryos recovered from deciduae at E6.5. Resorptions could not be genotyped except in the cases of one resorption (indicated by A ) that was m2z2Nf2, two resorptions (indicated by B ) that were m2z+Nf2, and one that was m2z2Nf2.
Dashed lines indicate inside cells. See also Figure S3 .
